Abstract :Bevacizumab is a monoclonal antibody, commonly used for treatment of stage IV non small cell lung cancer. We report the case of a patient which presented with a bevacizumab-induced aorto-caval fistula. The causality is based on the fact that no pre existing vascular abnormality was described on previous CT-scan. A surgical treatment was realized and is described in this report.